长叶eurycoma标准化提取物的体内抗疟原虫活性及急性毒性研究。传统上用于治疗疟疾的根

M. A. Wijayanti
{"title":"长叶eurycoma标准化提取物的体内抗疟原虫活性及急性毒性研究。传统上用于治疗疟疾的根","authors":"M. A. Wijayanti","doi":"10.3844/ajptsp.2014.24.28","DOIUrl":null,"url":null,"abstract":"A series of studies has been conducted to prove the Eurycoma longifolia Jack. root as an antimalarial. However, the in vivo antiplasmodial activity of E. longifolia Jack. root standardized extract and its lethal dos e 50% (LD50) values is unknown. In vivo antiplasmodial activity was conducted on Plasmodium berghei infected Swiss mice as malaria model with 4-day suppression methods. Sixty mice were divided into 6 gr oups. Five groups as treatment groups received test mater ial with 5 various doses and one group was given di stilled water as control group. Parasite growth inhibition was calculated by comparing the parasitemia at trea tment groups to control group. Effective dose that could inhibit parasite growth by 50% (ED50) was calculated by probit analysis based on the relationship between d ose and the percentage of parasite growth inhibitio n. The results showed that E. longifolia Jack. root standardized extract have in vivo antiplasmodial activity in P. berghei infected Swiss mice with ED50 value of 28.78 mg kg -1 . Acute toxicity testing was conducted on 60 mice, divided into 6 groups. Five groups received t est materials with 5 various doses as a single dose orally. One other group was given distilled water as contro l group. Each animal was observed for the first 24 h and observation was continued for 14 days. The lethal d ose 50% (LD50) was calculated by probit analysis based on the number of animal deaths that occurred within 24 h after the administration of the test material . The results showed that the LD50 value of E. longifolia Jack. root standardized extract was 6128.71 mg kg -1 . Therapeutic Index was calculated as ratio of the LD 50 and ED50 with results 212.95. It showed high therapeutic index which indicated that E. longifolia Jack. root standardized extract has low toxicity.","PeriodicalId":7769,"journal":{"name":"American Journal of Pharmacology and Toxicology","volume":"8 1","pages":"24-28"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"IN VIVO ANTIPLASMODIAL ACTIVITY AND ACUTE TOXICITY OF STANDARDIZED EXTRACT OF EURYCOMA LONGIFOLIA JACK. ROOT TRADITIONALLY USED TO TREAT MALARIA\",\"authors\":\"M. A. Wijayanti\",\"doi\":\"10.3844/ajptsp.2014.24.28\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A series of studies has been conducted to prove the Eurycoma longifolia Jack. root as an antimalarial. However, the in vivo antiplasmodial activity of E. longifolia Jack. root standardized extract and its lethal dos e 50% (LD50) values is unknown. In vivo antiplasmodial activity was conducted on Plasmodium berghei infected Swiss mice as malaria model with 4-day suppression methods. Sixty mice were divided into 6 gr oups. Five groups as treatment groups received test mater ial with 5 various doses and one group was given di stilled water as control group. Parasite growth inhibition was calculated by comparing the parasitemia at trea tment groups to control group. Effective dose that could inhibit parasite growth by 50% (ED50) was calculated by probit analysis based on the relationship between d ose and the percentage of parasite growth inhibitio n. The results showed that E. longifolia Jack. root standardized extract have in vivo antiplasmodial activity in P. berghei infected Swiss mice with ED50 value of 28.78 mg kg -1 . Acute toxicity testing was conducted on 60 mice, divided into 6 groups. Five groups received t est materials with 5 various doses as a single dose orally. One other group was given distilled water as contro l group. Each animal was observed for the first 24 h and observation was continued for 14 days. The lethal d ose 50% (LD50) was calculated by probit analysis based on the number of animal deaths that occurred within 24 h after the administration of the test material . The results showed that the LD50 value of E. longifolia Jack. root standardized extract was 6128.71 mg kg -1 . Therapeutic Index was calculated as ratio of the LD 50 and ED50 with results 212.95. It showed high therapeutic index which indicated that E. longifolia Jack. root standardized extract has low toxicity.\",\"PeriodicalId\":7769,\"journal\":{\"name\":\"American Journal of Pharmacology and Toxicology\",\"volume\":\"8 1\",\"pages\":\"24-28\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Pharmacology and Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3844/ajptsp.2014.24.28\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pharmacology and Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3844/ajptsp.2014.24.28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

已经进行了一系列的研究来证明长叶Eurycoma longifolia Jack。根作为抗疟药。然而,金针叶的体内抗疟原虫活性并没有明显的变化。根茎标准化提取物及其致死剂量50% (LD50)值未知。采用4 d抑制法对感染伯氏疟原虫的瑞士小鼠进行体内抗疟原虫活性研究。60只小鼠分为6组。5组作为治疗组给予5种不同剂量的试验物质,1组给予静水作为对照组。通过比较治疗组和对照组的寄生率计算寄生虫生长抑制率。根据d值与寄生虫生长抑制率的关系,采用概率分析法计算出抑制50%寄生虫生长的有效剂量(ED50)。根标准化提取物对伯氏线虫感染的瑞士小鼠具有体内抗疟原虫活性,ED50值为28.78 mg kg -1。将60只小鼠分为6组进行急性毒性试验。5组分别口服5种不同剂量的试验材料。另一组给予蒸馏水作为对照组。每只动物观察24 h,连续观察14 d。根据给药后24 h内动物死亡数,采用概率分析法计算致死剂量50% (LD50)。结果表明,金针叶的LD50值;根标准提取物6128.71 mg kg -1。以ld50与ED50之比计算治疗指数,结果为212.95。结果表明,该方法具有较高的治疗指标。根茎标准化提取物毒性低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
IN VIVO ANTIPLASMODIAL ACTIVITY AND ACUTE TOXICITY OF STANDARDIZED EXTRACT OF EURYCOMA LONGIFOLIA JACK. ROOT TRADITIONALLY USED TO TREAT MALARIA
A series of studies has been conducted to prove the Eurycoma longifolia Jack. root as an antimalarial. However, the in vivo antiplasmodial activity of E. longifolia Jack. root standardized extract and its lethal dos e 50% (LD50) values is unknown. In vivo antiplasmodial activity was conducted on Plasmodium berghei infected Swiss mice as malaria model with 4-day suppression methods. Sixty mice were divided into 6 gr oups. Five groups as treatment groups received test mater ial with 5 various doses and one group was given di stilled water as control group. Parasite growth inhibition was calculated by comparing the parasitemia at trea tment groups to control group. Effective dose that could inhibit parasite growth by 50% (ED50) was calculated by probit analysis based on the relationship between d ose and the percentage of parasite growth inhibitio n. The results showed that E. longifolia Jack. root standardized extract have in vivo antiplasmodial activity in P. berghei infected Swiss mice with ED50 value of 28.78 mg kg -1 . Acute toxicity testing was conducted on 60 mice, divided into 6 groups. Five groups received t est materials with 5 various doses as a single dose orally. One other group was given distilled water as contro l group. Each animal was observed for the first 24 h and observation was continued for 14 days. The lethal d ose 50% (LD50) was calculated by probit analysis based on the number of animal deaths that occurred within 24 h after the administration of the test material . The results showed that the LD50 value of E. longifolia Jack. root standardized extract was 6128.71 mg kg -1 . Therapeutic Index was calculated as ratio of the LD 50 and ED50 with results 212.95. It showed high therapeutic index which indicated that E. longifolia Jack. root standardized extract has low toxicity.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ribavirin Plus Therapy in Covid-19-A Single-Center Experience Drug Repositioning in Response to COVID-19 and other Challenging Diseases Drug Interactions Pharmacology: A Narrative Review Coenzyme Q10 Supplementation Effect on Systemic Diseases Association of remdesivir with poor clinical outcomes in Covid-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1